Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting.

Varadhan, Hemalatha; Ahuja, Vishal; Pitman, Catherine; Dwyer, Dominic E

Varadhan, Hemalatha; Ahuja, Vishal; Pitman, Catherine; Dwyer, Dominic E.

Varadhan H; NSW Health Pathology, NSW, Australia. Electronic address: hemalatha.varadhan@health.nsw.gov.au.
Ahuja V; NSW Health Pathology, NSW, Australia.
Pitman C; NSW Health Pathology, NSW, Australia.
Dwyer DE; NSW Health Pathology, NSW, Australia.

Pathology ; 54(1): 116-120, 2022 02.

Article in English | MEDLINE | ID: covidwho-1670991

Subject(s)

COVID-19; SARS-CoV-2; Humans; Molecular Diagnostic Techniques; Nasopharynx; Prevalence

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal: Pathology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google